Results 101 to 110 of about 50,246 (189)

Clofarabine combined with etoposide and cyclophosphamide for refractory and multiple relapsed childhood B-cell precursor acute lymphoblastic leukemia: an experience of the Polish Pediatric Leukemia/Lymphoma Study Group [PDF]

Acta Haematologica Polonica, 2020
Wachowiak, Jacek, Styczyński, Jan, Owoc-Lempach, Joanna, Gorczyńska, Ewa, Zaucha-Prażmo, Agnieszka, Kowalczyk, Jerzy, Szczepański, Tomasz, Balwierz, Walentyna   +7 more
openaire   +3 more sources

Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059

Clinical Pharmacokinetics
Inotuzumab ozogamicin is an antibody-drug conjugate approved for treating relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in adults. Pediatric pharmacokinetic data of inotuzumab ozogamicin are lacking.
Jen-Hao Wu, E. Pennesi, Francisco Bautista, May Garrett, Kei Fukuhara, Erica Brivio, A. Ammerlaan, Franco Locatelli, I. M. van der Sluis, C. Rossig, Christiane Chen-Santel, B. Bielorai, Arnaud Petit, Jan Starý, C. Díaz-de-Heredia, Susana Rives, Aengus O’Marcaigh, C. Rizzari, G. Engstler, K. Nysom, A. Rubio-San-Simón, B. Bruno, Y. Bertrand, B. Brethon, F. Rialland, G. Plat, U. Dirksen, L. Šrámková, C. Zwaan, A. Huitema   +29 more
semanticscholar   +1 more source

Human medicines European public assessment report (EPAR): Glivec, imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma,Gastrointestinal Stromal Tumors,Dermatofibrosarcoma,Myelodysplastic-Myeloproliferative Diseases,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Hypereosinophilic Syndrome, Date

Case Medical Research, 2019

semanticscholar   +1 more source

Drug‐Induced Cauda Equina Syndrome in an 8‐Year‐Old Boy With Acute Lymphoblastic Leukemia: An Uncommon Case Report

Clinical Case Reports
Intrathecal methotrexate can cause cauda equina syndrome in pediatric ALL patients, as demonstrated in this rare case of an 8‐year‐old boy. Symptoms included progressive limb weakness and urinary retention.
Marzieh Babaee, Mohsen Javadzadeh, Ali Hazeghi   +2 more
doaj   +1 more source

Gallic Acid Inhibits Proliferation and Induces Apoptosis in Lymphoblastic Leukemia Cell Line (C121)

Iranian Journal of Medical Sciences, 2016
Leukemia is known as the world’s fifth most prevalent cancer. New cytotoxic drugs have created considerable progress in the treatment, but side effects are still the important cause of mortality.
Zahra Sourani, Batoul Pourgheysari, Pezhman Beshkar, Hedayatollah Shirzad, Moein Shirzad   +4 more
doaj  

Adult <i>TWIST2</i>-high B-ALL confirms metabolic association but reveals molecular heterogeneity. [PDF]

Hemasphere
Walter W, Ecker V, Kern W, Stengel A.
europepmc   +1 more source

Challenges in the Diagnosis of Concurrent T-Lymphoblastic Leukemia/Lymphoma and Thymic Neuroendocrine Carcinoma: A Case Report. [PDF]

Case Rep Pathol
Oliveira K, Doan M, Pei Y, Yared M, Zhang S.   +4 more
europepmc   +1 more source

When Blasts Speak Louder Than Flow: A Diagnostic Challenge in Suspected Hematologic Malignancy. [PDF]

Cureus
Izadian Bidgoli A, Gomez Veliz A, Vermejo Blumen M, Noriega-Toledo D.   +3 more
europepmc   +1 more source

Extracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T-Cell Immunotherapy for B-Cell Malignancies: A Case Series. [PDF]

Hematol Oncol
Cavallaro G, Ferrari S, Pollastri A, Di Credico E, Meli C, Rondi M, Putelli A, Lussana F, Grassi A, Rambaldi A, Valetti TM, Riva I, Gritti G.   +12 more
europepmc   +1 more source

Utility of dual assessment of cyTRBC1 and cyTRBC2 by flow cytometry for identifying clonality in sCD3-negative to dimly expressing T cells. [PDF]

Blood Cancer J
Li M, Fu J, Li Y, Fan X, Zhang L, Zhou L, Zhang J, Zhang J, Xi Q.   +8 more
europepmc   +1 more source